期刊
BRAIN RESEARCH
卷 1265, 期 -, 页码 75-79出版社
ELSEVIER SCIENCE BV
DOI: 10.1016/j.brainres.2009.02.016
关键词
Memantine; KCC2; BDNF; GABA(A) receptor; Diazepam; Rotarod test
A 7-day treatment with memantine (25 mg/kg, i.p.), a drug that is currently prescribed for the treatment of Alzheimer's disease, increased the levels of brain-derived neurotrophic factor (BDNF) and reduced the expression of the neuron-specific K+/Cl- co-transporter, KCC2, in the hippocampus and cerebral cortex of mice. Knowing that KCC2 maintains low intracellular Cl(-)concentrations, which drive Cl- influx in response to GABA(A) receptor activation, we monitored the behavioural response to the GABAA receptor enhancer, diazepam, in mice pre-treated for 7 days with saline or 25 mg/kg of memantine. Memantine treatment substantially attenuated motor impairment induced by an acute challenge with diazepam (6 mg/kg, i.p.), as assessed by the rotarod test and the horizontal wire test. We suggest that a prolonged treatment with memantine induces changes in the activity of GABAA receptors that might contribute to the therapeutic and/or toxic effects of the drug. (C) 2009 Elsevier B.V. All rights reserved
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据